BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Expression Genetics, Inc. Specializing in DNA/RNAi Delivery and Therapeutics, Completes $12M Series B Financing

  August 4, 2008

   · 

  3 min read
• Deals

  Alnylam Pharmaceuticals Consolidates Intellectual Property for RNA Activation (RNAa), a New Biological Discovery for Activation of Gene Expression

  August 4, 2008

   · 

  7 min read
• Business

  Invitrogen Corporation, Lentigen Corporation to Provide Lentivirus Products and Services for Gene Over-Expression

  August 4, 2008

   · 

  4 min read
• Drug Development

  Pozen, Inc. Receives Initial FDA Response To PA32540 SPA

  August 4, 2008

   · 

  3 min read
• Drug Development

  Karo Bio AB Announces Successful Phase II Study with Eprotirome in Combination with Statin

  August 4, 2008

   · 

  4 min read
• Business

  Sucampo Pharmaceuticals, Inc. Appoints Jan Smilek Acting Chief Financial Officer

  August 4, 2008

   · 

  3 min read
• Business

  Noven Pharmaceuticals Inc. Announces Triggering of $25 Million Daytrana(R) Sales Milestone

  August 4, 2008

   · 

  3 min read
• Business

  Vertex Pharmaceuticals Incorporated Move a Big Victory for Boston

  August 4, 2008

   · 

  1 min read
• Business

  Biogen, Inc. Scouring Suburbs for 300,000 Square Feet

  August 4, 2008

   · 

  1 min read
• FDA

  Alkermes Announces Approval of VIVITROL(R) for the Treatment of Alcohol Dependence in Russia

  August 4, 2008

   · 

  5 min read